Experiences with dicumarol (3,3′methylene-bis-[4-hydroxycoumarin]) in the treatment of coronary thrombosis with myocardial infarction Preliminary report-Reference-Cited by-同舟云学术

Experiences with dicumarol (3,3′methylene-bis-[4-hydroxycoumarin]) in the treatment of coronary thrombosis with myocardial infarction Preliminary report

Published:1946-07 Issue:1 Volume:32 Page:20-31
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Wright Irving S.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference26 articles.

1. Studies of Hemorrhagic Sweet Clover Disease. I. The Preparation of Hemorrhagic Concentrates;Campbell;J. Biol. Chem.,1940

2. Studies of Hemorrhagic Sweet Clover Disease. II. The Bioassay of Hemorrhagic Concentrates by Following the Prothrombin in the Plasma of Rabbit Blood;Campbell;J. Biol. Chem.,1941

3. Studies of Hemorrhagic Sweet Clover Disease. VI. The Synthesis of the Delta—Diketone Derived From the Hemorrhagic Agent Through Alkaline Degradation;Huebner;J. Biol. Chem.,1941

4. The Anticoagulant Dicumarol;Link;Harvey Lect.,1943

5. Studies of the Hemorrhagic Agent, 3,3′-methylene-bis-(4-hydroxycoumarin); Its Effect on the Prothrombin and Coagulation Time of the Blood of Dogs and Humans;Bingham;Am. J. M. Sc.,1941

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CardioPulse Articles;European Heart Journal;2012-12

2. Coagulability of Blood in Acute Myocardial Infarction;Acta Medica Scandinavica;2009-04-24

3. THE SIGNIFICANCE OF HAEMORRHAGE DURING THE TREATMENT OF PATIENTS WITH THE COUMARIN ANTICOAGULANTS;Acta Medica Scandinavica;2009-04-24

4. Irving S. Wright-Innovator in cardiovascular medicine;Clinical Cardiology;1995-03

5. History of drugs for thrombotic disease. Discovery, development, and directions for the future.;Circulation;1994-01